No Detail Found!

Dose dependent effect of glycyrrhizin on glycaemic control of type 2 diabetic rats

Author(s)
Mufakhara Fatimah Department of Pharmacology, Post Graduate Medical Institute, Lahore, Pakistan; Department of Pharmacology, Sahara Medical College, Narowal, Pakistan
Mahwash Malik Department of Pharmacology, Post Graduate Medical Institute, Lahore, Pakistan; Department of Pharmacology, Avicenna Medical & Dental College, Lahore, Pakistan
Sidra Mushtaq Department of Pharmacology, Post Graduate Medical Institute, Lahore, Pakistan; D e p a r t m e n t o f P h a r m a c o l o g y, Independent Medical College, Faisalabad, Pakistan
Javeria Sarfraz Department of Pharmacology, Post Graduate Medical Institute, Lahore, Pakistan; Department of Pharmacology, King Edward Medical University, Lahore, Pakistan
Zobia Mushtaq Department of Pharmacology, Post Graduate Medical Institute, Lahore, Pakistan; Department of Pharmacology, Sahiwal Medical College, Sahiwal, Pakistan
Sadia Chiragh Department of Pharmacology, Post Graduate Medical Institute, Lahore, Pakistan; Department of Pharmacology, Al-Aleem Medical College, Lahore, Pakistan
Abstract
OBJECTIVE: To assess the effect of low and high dose of glycyrrhizin on body weight, fasting blood sugar level (FBSL), serum insulin and glycemic indices in high fat diet induced type 2 diabetic rats. METHODS: In this experimental study with intervention period of 34 weeks, rats were grouped into four experimental groups; Group-A: normal control; Group-B: diabetic control; Group-C: glycyrrhizin-150 and Group-D: glycyrrhizin-300. Diabetes mellitus was induced in rats by giving high fat diet with injection dexamethasone. At 32 weeks, body weight, FBSL, serum insulin, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), Homeostatic Model Assessment of beta cells (HOMA-ß) and Quantitative Insulin Sensitivity Check Index (QUICKI) were estimated. Two experimental groups received glycyrrhizin 150 mg/kg and 300 mg/kg per oral per day till completion of 34 weeks in addition to the high fat diet. At 34 weeks all the parameters were re-estimated. RESULTS: It was observed that both doses of glycyrrhizin significantly reduced FBSL and insulin levels in group-C (95.00±8.23 mg/dl, 671.60±55.51 µIU/ml) and group-D (94.00±6.27 mg/dl, 675.00±44.96 µIU/ml) as compared to group-B (236.10±13.26 mg/dl, 1052.80±37.82 µIU/ml) [p-value<0.001] at 34 weeks. HOMA-IR decreased [group-C (157.62±19.39) and group-D (157.03±18.21) vs group-B (613.79±49.91)] whereas HOMA-ß [group-C (2498.23±299.58) and group-D (2526.24±150.65) vs group-B (1546.87±106.81)] and QUICKI increased [group-C (0.208±0.00) and group-D (0.208±0.002) vs group-B (0.185±0.001)] (P-value<0.001). Body weight decreased insignificantly in group- C (344.00±30.21mg) (P-value>0.05) but significantly in group-D (293.20±42.54) as compared to group-B (372.00±24.03) [P-value<0.001]. CONCLUSION: Glycyrrhizin effectively improves glycaemic control in rat model of type 2 diabetes mellitus.
Publication Details
Page(s) 121-125
Published Journal: Khyber Medical University Journal, Volume: 12, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Diabetes Mellitus, Diabetes Mellitus, HOMA-IR, blood glucose, Glycemic Index, Experimental, QUICKI, HOMA-ß, Glycyrrhizin
0

Citations

0

Downloads

52

Views